We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Portable Device Could Test for Physical Property of Tumor Aggressiveness

By LabMedica International staff writers
Posted on 24 May 2015
Print article
Image: A user calibrates a newly developed portable polarimetric fiber stress sensor device while studying tumors by measuring Young’s modulus—an elasticity-related property recently linked to cancerous tumor aggressiveness (Photo courtesy of Kelvin Kuo, University of Southern California).
Image: A user calibrates a newly developed portable polarimetric fiber stress sensor device while studying tumors by measuring Young’s modulus—an elasticity-related property recently linked to cancerous tumor aggressiveness (Photo courtesy of Kelvin Kuo, University of Southern California).
A new polarimetric fiber stress sensor device has been developed for visco-elastic and biomimetic material analysis, and, as part of the emerging field of physical oncology, is being tested for measuring a tumor’s Young’s modulus—an elasticity-related measure recently linked to cancerous tumor aggressiveness.

Engineers from the Viterbi School of Engineering at the University of Southern California (LA, CA, USA) developed the device and in preliminary testing found that more aggressive tumors are generally stiffer, a complex relationship that requires further study. The device itself is an important step in the challenge of developing non-destructive methods to characterize physical properties of biological materials, and will be suitable for a wide variety of applications. It is an all-fiber-based material analysis device based on optical polarimetry that is different from previous polarimetric systems which rely on free-space components.

"The device leaves the sample completely undamaged, which allows researchers to still perform other tests on it," said Mark Harrison, USC engineering graduate student. Previous detectors required time-consuming alignment and were highly sensitive to environmental vibration. To solve these problems, the new device uses fiber optics, taking a cue from telecommunications. The system adds force onto a sample on top of the optical fiber, changing the polarization of the laser inside in a predictable way that enables calculation of the Young's modulus.

"Instruments able to measure a material's Young's modulus already existed, but they're large and require calibration each time they're moved," said Andrea Armani, USC associate professor of engineering, "Our device could be carried from hospital room to hospital room and doesn't need an engineer to operate it."

Prof. Armani was inspired after a conversation with colleague David Agus, USC professor of medicine and engineering, who told her that Young’s modulus has been linked to tumor aggressiveness but he lacked an easy-to-use device for testing that metric. "This advancement from Prof. Armani is so exciting, as we now have a new dimension of a tumor to measure. We are studying the role of Young's modulus together with Prof. Armani to help personalize and improve a cancer patient's care," said Prof. Agus.

In addition to evaluating the device's role in a clinical setting, there is also increased interest on a more fundamental level: understanding how different types of tumors are related to their mechanical properties. Emphasis has mostly been placed on the chemical makeup of tumors so most current tests to probe the nature of cancerous tumors focus on chemical makeup—an important feature to understand, but only part of whole the picture. "Physical oncology represents a completely fresh approach to tackling the problem of cancer. It has the potential to provide huge insights as scientists throughout the world try to understand, treat, and ultimately prevent cancer in humans," said Peter Kuhn, USC professor who helped launch a new peer-reviewed journal on physical oncology.

"Given how safe, stable, and accurate this instrument is, it could play a pivotal role in both diagnostic and research efforts," said Prof. Armani. The team next will work with Prof. Agus to test it in a clinical setting. They also hope to create a more sensitive version of the device that can map Young’s modulus across tumors.

The study, by Harrison MC and Armani AM, was published online May 14, 2015, in the journal Applied Physics Letters.

Related Links:
University of Southern California 
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.